Neutropenia as a side effect of prescrebing risperidone on adolescent with autism
1 Child and adolescent psychiatrist, Psychiatric Hospital Ibn Nafis, Marrakesh, Morocco.
2 Research team for mental health, University Cadi Ayyad, Marrakesh, Morocco.
Case Study
World Journal of Advanced Research and Reviews, 2022, 13(03), 360–362
Article DOI: 10.30574/wjarr.2022.13.3.0246
Publication history:
Received on 02 February 2022; revised on 19 March 2022; accepted on 21 March 2022
Abstract:
Neutropenia is an adverse effect of various pharmacological therapies, including antipsychotics. However, risperidone tends to have a lower risk of hematotoxicity. We report a case of a 14 years old boy with a diagnosis of autism who developed neutropenia after administration of risperidone and was able to resolved it after discontinuation. This is a rare case report of risperidone-induced neutropenia on adolescent.
Keywords:
Risperidone; Antipsychotics; Neutropenia; Blood dyscrasias; Adolescent
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0